Day 1 – Wednesday 3rd May
09:00 LSX Welcome Address
Nadia Konneh, Senior Conference Director, Healthtech Lead, LSX
09:10 Big Pharma’s Global Digital Health Priorities and Strategy
As pharma moves from a product to a platform focus, the highly strategic approach requires a focus on new infrastructure and services to meet the needs of customers in new ways. The chief heads of digital at top pharma companies will have a high-level discussion about their global digital health strategy, how they plan to improve the use of new tech across their companies, manage data better, foster successful partnerships and collaboration, and generally encouraging the digital health ecosystem worldwide.
Moderator: Sans Thakur, Chief Growth Officer, Medable
- What are your digital priorities (across the entire value chain)?
- How do you plan to manage data better?
- A look into the benefits of mining internal datasets vertically and what new insights can this yield?
- Insights into the challenges and opportunities of external collaboration and partnering with digital disruptors
- How do you develop and deploy patient/ physician facing solutions as quickly as possible?
Cristina Durán, Chief Digital Health Officer, R&D, AstraZeneca
Lisa Banks, VP, Global Head Digital Health & Innovation, GSK
Emre Ozcan, VP, Global Head of Digital Health, Merck
09:50 Keynote Panel: Scaling Digital Health Companies and Creating Commercially Viable Business Models
With countries and regions across the globe developing and enforcing a plethora of overlapping (and in some cases confusing) regulations on data privacy, protection, and localization, and with EU regulations such as the Digital Markets Act, it is making it difficult for digital health companies to scale up. With profitability also a priority, it is imperative for digital health companies to develop commercially viable business models. This discussion will highlight case studies and best practices for global expansion in the EU & US.
Moderator: Andrea Zitna, Partner, Speedinvest
- How the EU’s fragmented digital markets make it hard for companies to scale and what can be done?
- Is the EU prioritising regulation over innovation?
- How do we make Europe a destination of choice for scale up?
- How to drive global expansion into the US market
- Best practices for successful digital health business models in Europe and the US
Mark Jenkins, Co-Founder, Oviva
Lukas Didon, Commercial & Partnerships VP, Kry
Konstantin Mehl, CEO, Kaia Health
Rebecca Gwilt, Partner, Nixon Gwilt Law
10:30 Morning Break
11:10 Panel: The Ongoing Digital Transformation of the Healthcare Industry - Entering a New Era of Digital Health at Scale
Christian Hein, Global Head of Digital Transformation & Innovation Execution, Novartis
- The realities of digitally transforming a pharma/ healthcare company and the way they work
- Sharing the wins – what has worked well in your digital transformation journey?
- How can we go further in making our processes more user-centric and efficient?
- The importance of digital innovation to better serve patients, physicians and improve outcomes
- Digitalising and improving treatment algorithms– how can you even digitalise this?
Joerg Corsten, Senior Digital Transformation & Innovation Director, Roche
Thomas Hummel, Head of Digital Transformation, Fresenius Kabi
Michelle Longmire, CEO, Medable
12:00 Panel: Creating Successful Digital Health-Pharma Partnerships and Collaborations
Moderator: Laura Wamprecht, Managing Director, Flying Health
- Partnering with Pharma – what are commercial leaders looking for?
- The need for new collaboration models
- Overcoming roadblocks in digital health and DTx partnerships and collaborations
- How to create win-win partnerships between big pharma and digital innovators
- How to implement AI, machine learning and other emerging technologies into worldwide innovation
- What is the M&A market looking like?
Mats Berggren, Head of Search & Evaluation, Digital Innovation & External R&D, Merck
Sophie Park, Managing Director, Digital Health, Bayer Pharmaceuticals
Susanne Gruber, Interim CEO, eyelevel GbmH
Sarah Beeby, Former Managing Director, Liva Healthcare
Valerie Hepp, Digital and PHC Partnering Europe and Asia Lead, Roche
12:50 Lunch Break
14:00 Panel: Getting a Digital Therapeutic Approved and Reimbursed in Europe
Moderator: Eveline Van Keymelen, Partner, Latham & Watkins
- Case studies from DTx companies that have therapeutics approved in Europe
- How to succeed in a fragmented European regulatory landscape
- An overview of the main DTx reimbursement frameworks and practical examples on getting DTx reimbursed
- The challenges of demonstrating evidence across different regulatory and reimbursement requirements
- Commercialisation models: what is working, what is not
Megan Coder, Chief Policy Officer, Digital Therapeutics Alliance
Francesca Domenech Wuttke, Founder & CEO, nen health
Hannes Klopper, CEO, Co-Founder, HelloBetter
Damien McKeon, SVP, Global Strategic Alliances, Aptar Digital Health
14:50 Panel: Evaluating the Digital Therapeutics Investment Landscape Over the Past Year
Moderator: Marc Sluijs, Founder, DigitalHealth.Network
- How do we get to scale?
- M&A and consolidation: What are the trends?
- Discussing the willingness of investors to fund non-organic growth strategies
- What has been the effect of digital therapeutics companies going public?
- Has adoption been consistent with expectations? (Usage, prescription, revenues generated)
Ingrid Teigland Akay, Managing Partner, Hadean Ventures
Edward Kliphuis, Partner, Sofinnova Partners
Christian Lautner, Managing Partner, Heal Capital
Lana Ghanem, Managing Director, Hikma Ventures
Vishal Gulati, Managing Director, Recode Ventures
15:40 Afternoon Break
16:20 Panel: Assessing the Progress in the Women’s Health Space
Moderator: Annemijn Eschauzier, Independent Advisor & Board Member
- Can we match the level of deal flow seen in general health?
- What funding opportunities are out there? Where are the funding gaps?
- Insights on how to raise capital - What are investors looking for from women’s health companies?
- Building a product that is consumer friendly and medical grade
- Closing the education gap and improving health literacy
Evie Mulberry, Managing Partner, Astia Fund
Priya Oberoi, General Partner, Goddess Gaia Ventures
Keren Leshem, CEO, OCON Healthcare
Carrie Walter, Co-CEO, Clue
17:00 Closing Keynote Panel- The Healthtech Funding Slump: Are We on The Way Back Up?
Moderator: Tina Tan, Executive Editor, FirstWord HealthTech
- Lessons learned from 2021 and 2022 VC investments in healthtech
- An overview of the European digital health investment activity over the past year
- Digital health M&A activity in Europe and US
- Assessing the current valuation environment
- Notable transactions and growing digital health companies in Europe and US
- What’s next for healthtech funding, finance and investment?
Christoph Kausch, Managing Partner, MTIP
Samuel Levy, Founding Partner, Lauxera Capital Partners
Robert Garber, Partner, 7wire ventures
Clara Campàs, Managing Partner, Asabys
Marta Gaia Zanchi, Managing Partner, Nina Capital
17:40 Drinks Reception
Day 2 – Thursday 4th May
09:00 LSX Welcome Address
Nadia Konneh, Senior Conference Director, Healthtech Lead, LSX
09:10 Keynote Panel: Is Population Health Management Going to Save Healthcare?
Population health management (PHM) is a whole system approach which aims to improve the health of an entire population, while reducing health inequalities. Digital technologies can be used in PHM to enable earlier treatment and diagnosis, large-scale clinical trials, and collect evidence to assess how effective new treatment pathways are.
Moderator: Mark Davies, Chief Medical Officer, IBM
- How can health systems, payers and digital health companies can work together to support population health management?
- Exploring the relationship between service redesign and analytics
- Population health management strategies to reduce health disparities
- Genomics as a population health management tool in the transition to value-based care
- A spotlight on innovative digital health companies that are building solutions for population health management
Geraint Lewis, Director of Population Health, Microsoft
Shirlene Oh, Chief Strategy and Population Health Officer, Hampshire Hospitals NHS Foundation Trust
Ann Aerts, Head of the Novartis Foundation
09:50 Driving Greater Adoption of HealthTech Innovation Within the NHS and Ensuring a Patient Centric Experience
HealthTech innovation is integral to resolving the long-term challenges faced by the NHS, but many providers in the sector are having difficulty adopting and realising their full potential. What can we do to drive greater adoption and enhance the experience for patients and clinicians?
Moderator: Tom Houston, Healthcare – Client Partner, Gobeyond Partners
- Outlining the challenges of HealthTech adoption and how we can overcome this
- How can HealthTech innovation solve the long-term challenges faced by healthcare systems like the NHS?
- Aligning patient/physician perspectives and empowering providers with the full potential of HealthTech solutions
Emma Bouché, Head of Healthcare, Webhelp
Michael Macdonnell, Global Head of Healthcare, Huma
Toby Basey-Fisher, CEO & Founder, Entia
10:30 Morning Break
11:10 Panel: Leveraging Real-World Evidence and Real-World Data
Moderator: Ronjon Nag, Founder & President, R42 Group
- How is RWE being used and regulated?
- Assessing the adoption of RWD/RWE in R&D and commercially
- How is RWD being used post product approval? How are products being improved upon?
- How have technological advancements helped in scaling the use of RWD/RWE?
Dan Vahdat, CEO, Huma
Sam Oddsson, Co-Founder & Chief Clinical Officer, SidekickHealth
Ivana Naeymi-Rad, Chief Operating Officer, Intelligent Medical Objects
Yacine Hadjiat, Global Head of Digital Solutions, Biogen
12:00 Panel: Making Value-Based Healthcare a Reality
Assaf Barnea, Managing Partner, Sanara Capital & Sanara Ventures
- What exactly do we mean by “value-based healthcare”?
- Is value-based healthcare a sustainable business model?
- How do you demonstrate value to regulators?
- Paying for value and not volume – connecting value to outcomes
- How can digital health drive value-based healthcare?
Joe Stringer, Partner, Octopus Ventures
Jeffrey Scott, President & Chief Medical Officer, Integra Connect
Andrei Soran, Former CEO, Pipeline Health
12:50 Lunch Break
14:00 The race to the Exit: Are Europe’s Digital Health Start-Ups Keener Than Ever to Be Acquired?
Has the healthtech sector emerged unscathed from the market downturn? There has been an increase of digital health start-ups that have been acquired or bought out in the past year, and many more are looking to exit. Hear from companies and investors about why this is and the impact of the external funding environment on digital health start-ups willingness to exiting.
Ranjan Singh, Co-Founder, HealthHero
- Profitability is priority-the shift in what investors are looking
- The decrease in valuations and cheque sizes
- The need for more capital and the long timeframes to scale profitability for digital health start-ups
- A digital health M&A wave – insight from start-ups who have gone through the acquisition process with larger companies
Elina Halatcheva, Managing Partner, Brightcap Ventures
Caroline Noublanche, CEO & Co-Founder, Apricity
Gregoire Guillet, Chief Business and Value Officer, WeHealth Digital Medicine - Servier
14:40 Panel: Digital Mental Health 2.0 – Scaling Behavioural Healthtech
Moderator: Joao Barbosa da Silva, Senior Associate, re.Mind Capital
- Funding has poured into behavioural health technology start-ups and innovations these last few years, but is it sustainable?
- What are the key challenges in scaling mental health start-ups?
- Building a scalable mental health business model
- Taking an evidence-based approach to mental healthcare tech innovation
Georgi Natchev, CEO, Digiburn
Harry Briggs, Managing Director, OMERS Ventures
Linisha Palm, CEO, We.Care
Steve Tolle, General Partner, HLM Venture Partners
15:20 Closing Keynote Panel: How do we build trust in Digital Technology, AI and Data Use?
Moderator: Charles Lowe, CEO, Digital Health & Care Alliance
- Ethical data usage in an era of digital technology and regulation
- The patient as the ultimate data owner
- Engaging the patient in genuine dialogue to build trust in a new digital world
Mark Davies, Chief Medical Officer, IBM
Liz Ashall-Payne, CEO & Co-Founder, ORCHA Healthcare
Natalie Banner, Director of Ethics, Genomics England
Andrew Davies, Digital Health Lead, ABHI
16:00 Close of Congress